[HTML][HTML] Novel Mutations in BMPR2, ACVRL1 and KCNA5 Genes and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension

G Pousada, A Baloira, C Vilariño, JM Cifrian… - PLoS …, 2014 - journals.plos.org
Background Pulmonary arterial hypertension (PAH) is a rare and progressive vascular
disorder characterized by increased pulmonary vascular resistance and right heart failure. The …

[HTML][HTML] Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients

…, C Pérez-Olivares, P Escribano-Subías, G Pousada… - Scientific Reports, 2020 - nature.com
Pulmonary Arterial Hypertension (PAH) is a rare and fatal disease where knowledge about
its genetic basis continues to increase. In this study, we used targeted panel sequencing in a …

[HTML][HTML] Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV

…, I De los Santos, S De la Fuente, G Pousada… - Viruses, 2023 - mdpi.com
Background: The high effectiveness and safety of the two-drug (2DRs) strategy using dolutegravir
(DTG) plus lamivudine (3TC) have led to international guidelines recommending their …

[HTML][HTML] Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial Hypertension

G Pousada, V Lupo, S Cástro-Sánchez… - Scientific Reports, 2017 - nature.com
Pulmonary arterial hypertension is a progressive disease that causes the obstruction of
precapillary pulmonary arteries and a sustained increase in pulmonary vascular resistance. The …

[HTML][HTML] Mutational and clinical analysis of the ENG gene in patients with pulmonary arterial hypertension

G Pousada, A Baloira, D Fontán, M Núñez, D Valverde - BMC genetics, 2016 - Springer
Background Pulmonary arterial hypertension (PAH) is a rare vascular disorder characterized
by a capillary wedge pressure ≤ 15 mmHg and a mean pulmonary arterial pressure ≥ 25 …

[HTML][HTML] Dolutegravir plus rilpivirine: Benefits beyond viral suppression: DORIPEX retrospective study

…, J Gómez, E Delgado, E Moreno-García, G Pousada… - Medicine, 2022 - journals.lww.com
… Delgado 10 , Estela Moreno-García 11 , Guillermo Pousada 12 , Alexandre Pérez 12 ,
Teresa Aldamiz 13 , … Guillermo Pousada’s name has been corrected from Guillermo Posada. …

[HTML][HTML] Molecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmonary arterial hypertension

G Pousada, A Baloira, D Valverde - Orphanet journal of rare diseases, 2015 - Springer
Background Pulmonary arterial hypertension (PAH) is a rare and progressive vascular
disorder characterized by increased pulmonary vascular resistance and right heart failure. The …

[HTML][HTML] Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 …

…, A Díaz de Santiago, MÁ Morán, G Pousada… - Viruses, 2023 - mdpi.com
Dolutegravir (DTG) based dual therapies for treating PLWHIV are a standard of care
nowadays. Switching to DTG and lamivudine (3TC) safety and efficacy were proven in TANGO …

[HTML][HTML] Complex inheritance in Pulmonary Arterial Hypertension patients with several mutations

G Pousada, A Baloira, D Valverde - Scientific Reports, 2016 - nature.com
Pulmonary Arterial Hypertension (PAH) is a rare and progressive disease with low
incidence and prevalence, and elevated mortality. PAH is characterized by increased mean …

Methylation analysis of the BMPR2 gene promoter region in patients with pulmonary arterial hypertension

G Pousada, A Baloira, D Valverde - Archivos de Bronconeumología …, 2016 - Elsevier
Introduction Pulmonary arterial hypertension is characterized by obstruction of the pulmonary
arteries. The gene, mainly related to pathology, is the bone morphogenetic protein …